| Active ingredient (INN) | Cefazolin |
|---|---|
| Brand names | Cefazolin For Injection Usp |
| ATC level 5 | J01DB04 |
| ATC level 4 | J01DB |
| Therapeutic category | Auto-created by Health Canada — Drug Shortages Database scraper |
| WHO Essential Medicine | Yes (2023) |
| Controlled substance | No |
| Marketing-authorisation holders | Southern Cross Pharma Pty Ltd, AFT Pharmaceuticals Pty Ltd, NORIDEM ENTERPRISES LIMITED, MIP PHARMA GMBH +6 more |
| Registrations on file | 28 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Sxp | 1000 mg | — | 🇦🇺 AU | Southern Cross Pharma Pty Ltd | Active |
| AFT cefazolin sodium | 2 g | — | 🇦🇺 AU | AFT Pharmaceuticals Pty Ltd | Active |
| CEFAZOLIN 1G POWDER FOR SOLUTION FOR INJECTION/INFUSION | 1G | injection | 🇬🇧 GB | NORIDEM ENTERPRISES LIMITED | Active |
| CEFAZOLIN 2G POWDER FOR SOLUTION FOR INJECTION/INFUSION | 2G | injection | 🇬🇧 GB | NORIDEM ENTERPRISES LIMITED | Active |
| CEFAZOLIN 2 G, POWDER FOR SOLUTION FOR INJECTION / INFUSION | 2 G | injection | 🇬🇧 GB | MIP PHARMA GMBH | Active |
| Cefazolin | 2g/1 | injection | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |
| Cefazolin | 3g/1 | injection | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |
| Cefazolin | 10g/1 | injection | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |
| Cefazolin | 330mg/mL | injection | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |
| Cefazolin | 20g/1 | injection | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |
| Cefazolin | 225mg/mL | injection | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |
| KEFZOL cefazolin | 1g | — | 🇦🇺 AU | Aspen Pharmacare Australia Pty Ltd | Active |
| KEFZOL cefazolin | 500mg | — | 🇦🇺 AU | Aspen Pharmacare Australia Pty Ltd | Active |
| Juno | 500mg | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |
| Juno | 1g | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |